Life Biosciences this week began the first FDA‑approved human trial of an anti‑ageing therapy, ER‑100, targeting optic‑nerve cells in glaucoma patients. The approach uses cellul...
Scientists and startups are converging on two very different routes to extend life: biological rejuvenation and digital afterlives. This article surveys the real progress, remai...
We use cookies
We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept", you consent to our use of cookies.
